About Ernexa Therapeutics Inc. Common Stock
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.
Market Cap
$0.01B
Employees
6
Listed Since
March 26, 2021
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.eternatx.comPhone
(212) 582-1199
Headquarters
1035 CAMBRIDGE STREET
CAMBRIDGE, MA 02141
CIK
0000748592